Details

Autor(en) / Beteiligte

• Taghizadeh, Sara
• Chao, Cho-Ming
• Guenther, Stefan
• Glaser, Lea
• Gersmann, Luisa
• Michel, Gabriela
• Kraut, Simone
• Goth, Kerstin
• Koepke, Janine
• Heiner, Monika
• Vazquez-Armendariz, Ana Ivonne
• Herold, Susanne
• Samakovolis, Christos
• Weissmann, Norbert
• Ricci, Francesca
• Aquila, Giorgio
• Boyer, Laurent
• Ehrhardt, Harald
• Minoo, Parviz
• Bellusci, Saverio
• Rivetti, Stefano

Titel

FGF10 triggers de novo alveologenesis in a BPD model: impact on the resident mesenchymal niche cells

Ist Teil von

• Stem cells (Dayton, Ohio), 2022-04

Ort / Verlag

England

Erscheinungsjahr

2022

Link zum Volltext

Quelle

EZB-FREE-00999 freely available EZB journals

Beschreibungen/Notizen

• Bronchopulmonary dysplasia (BPD) is a neonatal lung disease developing in premature babies characterized by arrested alveologenesis and associated with decreased Fibroblast growth factor 10 (FGF10) expression. One-week hyperoxia (HYX) exposure of newborn mice leads to a permanent arrest in alveologenesis. To test the role of Fgf10 signaling to promote de novo alveologenesis following hyperoxia, we used transgenic mice allowing inducible expression of Fgf10 and recombinant FGF10 (rFGF10) protein delivered intraperitoneally. We carried out morphometry analysis, and IF on day 45. Alveolospheres assays were performed co-culturing AT2s from normoxia (NOX) with FACS-isolated Sca1 Pos resident mesenchymal cells (rMC) from animals exposed to NOX, HYX-PBS, or HYX-FGF10. scRNAseq between rMC-Sca1 Pos isolated from NOX and HYX-PBS were also carried out. Transgenic overexpression of Fgf10 and rFGF10 administration rescued the alveologenesis defects following HYX. Alveolosphere assays indicate that the activity of rMC-Sca1 Pos is negatively impacted by HYX and partially rescued by rFGF10 treatment. Analysis by IF demonstrates a significant impact of rFGF10 on the activity of resident mesenchymal cells. scRNAseq results identified clusters expressing Fgf10, Fgf7, Pdgfra, and Axin2, which could represent the rMC niche cells for the AT2 stem cells. In conclusion, we demonstrate that rFGF10 administration is able to induce de novo alveologenesis in a BPD mouse model and identified subpopulations of rMC-Sca1 Pos niche cells potentially representing its cellular target.